Inspections, Compliance, Enforcement, and Criminal Investigations
Belcorp of America - Close Out Letter 11/17/11
| Public Health Service Food and Drug Administration |
| Center for Tobacco Products 9200 Corporate Boulevard Rockville, MD 20850-3229 |
NOV 17 2011
VIA UPS and Fax
Roberto R. Ribeiro
President
Belcorp of America
1759 NW 79th Avenue
Doral, FL 33126
Fax: (305) 597-0500
Dear Mr. Ribeiro:
FDA’s Center for Tobacco Products has completed an evaluation of your corrective actions following the issuance of our Warning Letter dated June 27, 2011. Based on our evaluation, it appears that you have addressed the violation(s) contained in the Warning Letter by removing all violative material from the website http://www.belcorpfactorydirect.com .
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Sincerely,
/s/
El lbarra-Pratt
Group Leader
Promotion, Advertising, and Labeling Group
Office of Compliance and Enforcement
Center for Tobacco Products





Department of Health and Human Services

